DUBLIN–( BUSINESS WIRE )– Research and Markets ( ) has announced the addition of the “Liver Cirrhosis Pipeline Highlights – 2014 Update” report to their offering.
The latest report Liver Cirrhosis Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Liver Cirrhosis market. It covers emerging therapies for Liver Cirrhosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Liver Cirrhosis pipeline molecules by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Liver Cirrhosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug